Table 1 Summary of reported cases of TAK with coronary involvement treated with drug-eluting stent and/or drug-coated balloon dilation
Literature | Age | Sex | Stenosis of coronary artery in CAG 1 | Involved coronary artery and PCI or surgery 1 | Pre-PCI medicine 2 | Post-PCI medicine 3 | PCI Follow-up duration 4 | Symptoms after PCI | Follow-up CAG after PCI |
|---|---|---|---|---|---|---|---|---|---|
Furukawa Y, 2005 [12] | 53 | F | Stenosis of LMCA (90%) and distal bifurcation. | The 1st PCI: Ostial LMCA: bare metal stent; The 2nd PCI: LMCA-ISR: sirolimus-eluting stent. | Pred. | Not reported. | 6 months. | Asymptomatic. | Minimal luminal narrowing in the LMCA and ostial LCX. |
Amir O, 2006 [16] | 22 | F | Stenosis of LMCA (60%). | Ostial LMCA: paclitaxel-eluting stent. | Anti-inflammatory therapy for 3 weeks (undetailed). | Steroid therapy. | 3 months. | Asymptomatic. | An unimpeded stent without new lesions. |
Sakai H, 2006 [28] | 37 | F | Stenosis of LMCA. | The 1st: CABG; Post-CABG PCI: LMCA-LAD: zotarolimus-eluting stents; LMCA-LCX: zotarolimus-eluting stents. | Not reported. | Steroid therapy. | 4 months. | Asymptomatic. | No new coronary lesions. |
Park JS, 2009 [17] | 37 | M | Stenosis of ostial LAD (95%) and LCX (95%) and RCA (99%). | Ostial LAD: paclitaxel-eluting stent; Ostial LCX: paclitaxel-eluting stent; Ostial RCA: paclitaxel-eluting stent. | Pred. | Pred. | 6 months. | Asymptomatic. | A patent stent without new lesions. |
Lee K, 2010 [13] | 35 | F | The 1st CAG: Stenosis of LMCA and RCA; The 2nd CAG: ISR of ostial RCA. | The 1st PCI: Ostial LMCA: paclitaxel-eluting stent; RCA: bare metal stent; The 2nd PCI: ISR of RCA: sirolimus-eluting stent. | Not reported. | No use of immunosuppressants. | 5 years. | Relapse of angina. | 3rd CAG showing severe restenosis at LMCA and RCA. The patient took CABG. |
Terasawa A, 2010 [18] | 66 | F | Stenosis of LMCA at anastomosis to graft (history of Bentall operation). | Ostial LMCA: sirolimus-eluting stent. | No use of steroid therapy. | Steroid therapy. | 12 months. | Asymptomatic. | No new coronary lesions. |
Lee HK, 2011 [14] | 54 | F | The 1st CAG:Stenosis of ostial LMCA (60%); The 2nd CAG: LMCA-ISR (75%); The 3rd CAG: Restenosis of the in-stent site (≥ 90%). | The 1st PCI: LMCA: a stent; The 2nd PCI: LMCA: paclitaxel-eluting stent; The 3rd: CABG. | No use of anti-inflammatory therapy. | No use of anti-inflammatory therapy. | 3 months. | Asymptomatic after the 1st PCI. Chest pain and dyspnea after the 2nd PCI. Asymptomatic after CABG. | No new stenosis or graft stenosis 1 year after CABG. |
Cheng Z, 2011 [19] | 27 | F | Stenosis of LMCA (95%) and ostial RCA (90%). | Ostial LMCA: sirolimus-eluting stent. | Pred. | Not reported. | Not reported. | Asymptomatic. | Not reported. |
Yokota K, 2012 [29] | 52 | F | The 1st CAG: Stenosis of the proximal LAD; The 2nd CAG: ISR of LAD (75%); The 3rd and 4th CAG:Stenosis only in the stent site with no other plaque progression or new stenosis. | The 1st PCI: proximal LAD: sirolimus-eluting stent; The 2nd PCI: LAD-ISR: sirolimus-eluting stent; The 3rd and 4th PCI: no stent implantation. | Steroid therapy (The drug was withdrawn due to the inactivity of the arteritis). | Steroid therapy (starting after the 4th PCI). | About 2 years. | Repeated chest pain during 1st to 4th PCI. | Patent stent site. |
Isser HS, 2013 [20] | 15 | F | Stenosis of ostial LMCA (90%) and normal LAD, LCX and RCA. | Ostial LMCA: zotarolimus-eluting stent. | Not reported. | Steroid therapy. | 1 year. | Asymptomatic. | A patent stent in LMCA. |
Soeiro Ade M, 2013 [15] | 33 | F | The 1st and 2nd CAG:Not reported; The 3rd CAG: LAD-ISR (75%). | The 1st PCI: LMCA: bare metal stent; The 2nd PCI: sirolimus-eluting stent; The 3rd: CABG. | MTX and Pred. | Pred, MMF and chloroquine after CABG. | 18 months. | Chest pain after 2nd PCI. Asymptomatic after CABG. | No new stenosis or graft stenosis. |
Camuglia AC, 2015 [21] | 21 | F | Stenosis of LMCA with a normal RCA. | Ostial LMCA: bioresorbable vascular scaffold. | Not reported. | Pred and Aza. | 8 months. | Asymptomatic. | No new coronary lesions. |
Rigatelli G, 2016 [22] | 41 | F | Stenosis of LMCA and RCA. | Ostial LMCA: paclitaxel-eluting stent; RCA: paclitaxel-eluting stent. | Not reported. | Steroid therapy. | Not reported. | Asymptomatic. | Not reported. |
Empen K, 2017 [30] | 24 | F | The 1st CAG: Stenosis of LMCA; The 2nd CAG: LMCA-ISR. | The 1st PCI: Ostial LMCA: everolimus-eluting stent; The 2nd: CABG. | Not reported. | Pred and CTX (after 1st PCI); Pred and tocilizumab (after 2nd CAG and before CABG). | Not reported. | Recurrent angina after 1st PCI. Asymptomatic after CABG. | Not reported. |
Macedo LM, 2019 [31] | 23 | F | The 1st CAG: Stenosis of LAD and LCX; The 2nd CAG: Stenosis of LMCA and venous graft (70%) with normal arterial graft. | The 1st: CABG; Post-CABG PCI: Venous graft-LAD: drug-eluting stent. | Not reported. | Pred and MTX after CABG; Not reported after PCI. | Not reported. | Chest pain after CABG. Asymptomatic after post-CABG PCI. | Not reported. |
Sammel AM, 2019 [32] | 55 | F | The 1st CAG: Stenosis of ostial LAD (99%) and RCA (100%); The 2nd CAG: ISR of ostial LAD (90%); The 3rd CAG: Stenosis of LAD and venous graft (95%). | The 1st PCI: LAD: zotarolimus-eluting stent; The 2nd: CABG. | Not reported. | DAPT after the 1st PCI; Immunosuppressive therapy with Pred and MTX 6 months after CABG. | 36 months. | Chest pain after the first PCI and CABG. Asymptomatic after immunosuppressive Drugs. | Not reported. |
Shimizu T, 2020 [33] | 55 | F | The 1st CAG: Stenosis of ostial LAD (90%) and LCX (99%); The 2nd CAG: Restenosis of ostial LAD, ostial LCX and LMCA. | The 1st PCI: Ostial LAD: coronary atherectomy catheter and paclitaxel-coated balloon; The 2nd: CABG. | Not reported. | Pred after CABG. | 12 months. | Asymptomatic after CABG and Pred prescription. | Not reported. |
Madhavan MV, 2020 [34] | 17 | F | The 1st CAG: Stenosis of LMCA, ostial RCA (60%), and right-to-left collaterals; The 2nd CAG: Stenosis of SVG-RCA, LIMA-obtuse marginal (70 and RIMA-LAD (70%). | The 1st: CABG; Post-CABG PCI: LMCA: zotarolimus-eluting stents. | Steroid therapy. | Pred, MTX and tocilizumab. | 6 months. | Recurrent chest pain after CABG. Asymptomatic after post-CABG PCI. | No performance due to the patient’s refusal. |
Zhou S, 2021 [23] | 22 | F | Stenosis of ostial LMCA and RCA. | Staged PCI: RCA: sirolimus-eluting stent. | Not reported. | Pred and MTX. | 15 months. | Asymptomatic. | Regression of ostial LMCA and a patent RCA stent |
Chiew KLX, 2021 [24] | 47 | F | Stenosis of LAD and LMCA. | Proximal LAD to LMCA: drug-coated balloon. | Aza. | Aza first. After the follow-up CAG, Pred, and tocilizumab were used, but lastly, only MTX. | 4 months. | Asymptomatic. | No new stenosis. |
Chen Q, 2022 [35] | 41 | F | The 1st CAG: Stenosis of ostial LMCA (40%), LAD (75% in proximal segment and 90% in middle segment), LCX (80%) and ostial RCA (90%); The 2nd CAG: Stenosis of ostial LMCA (75%) with patent stent in LAD. | The 1st PCI: LAD: zotarolimus-eluting stent; RCA: zotarolimus-eluting stent. | Not reported. | Steroid therapy was stopped until there was no increase in CRP and ESR. | Not reported. | Chest discomfort after the 1st CAG, and she refused post-PCI CABG. | Not reported. |